We are live on ! Find out more

426 hedge funds and large institutions have $6.62B invested in Chemed in 2021 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 127 increasing their positions, 155 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more call options, than puts

Call options by funds: $13.9M | Put options by funds: $10.4M

8% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 53

1% more funds holding

Funds holding: 422 → 426 (+4)

2.16% less ownership

Funds ownership: 89.51% → 87.34% (-2.2%)

18% less repeat investments, than reductions

Existing positions increased: 127 | Existing positions reduced: 155

32% less capital inflows, than outflows

Capital inflows: $415M | Capital outflows: $611M

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
426
Holders Change
+4
Holders Change %
+0.95%
% of All Funds
7.39%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
57
Increased
127
Reduced
155
Closed
53
Calls
$13.9​M
Puts
$10.4​M
Net Calls
+$3.47​M
Net Calls Change
+$3.22​M

CHE Hedge Fund Activity: Q2 2021 in Review

426 of the 5,768 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q2 2021, worth a combined $6.62B — up 0.29% from $6.6B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new CHE positions and 53 closed out — a net gain of 4 holders — while 127 added to existing stakes and 155 trimmed.

The largest buyer was Boston Trust Walden, adding an estimated $33.2M. The largest seller was BlackRock, cutting an estimated $46M.

  • 426 institutional investors held Chemed (CHE) as of Q2 2021, up from 422 in Q1 2021.
  • Funds reported $6.62B of Chemed stock for Q2 2021, up 0.29% quarter-over-quarter.
  • 57 funds opened new Chemed positions in Q2 2021 and 53 closed out, a net change of +4 holders.
  • The largest Chemed buyer in Q2 2021 was Boston Trust Walden, an estimated $33.2M added.
  • The largest Chemed seller in Q2 2021 was BlackRock, an estimated $46M sold.

Based on aggregated 13F filings for Q2 2021.